It is known that the MMP-9/NGAL ratio is a better biomarker in the differentiation of MCNS (minimal change nephrotic syndrome) and FSGS in children with nephrotic syndrome than the individual use of each molecule [94,96]. Here, MMP9 is linked to focal segmental glomerulosclerosis.